Stronger tourism activity poised to spur economy. PETALING JAYA: The effect of stronger tourism activity is expected to boost Malaysia’s gross domestic product (GDP) by at least one percentage point (ppt) in 2023, via further recovery in tourist arrivals, resumption of China outbound travelling, and sustained domestic tourism demand.
In a report, UOB Global Economics and Markets Research says the expected stronger tourism activity further supports its economic growth forecast of 4% for Malaysia in 2023.
The research unit pointed out that the global tourism sector is expected to make a big leap this year as China reopens its borders.
So far more good news than bad news for GB. But there is a few keep writing bad comments about GB and I don't think they are having any GB shares. I am not sure why they keep writing since they are not interested in GB and what is their motive.
PETALING JAYA: Casinos in Malaysia and Singapore are expected to enjoy a buoyant 2023, with the return of China tourists, following the full borders reopening of the world’s second-largest economy.
This is set to benefit Genting Bhd, the largest casino conglomerate in South-East Asia, with interests in power, plantations, property and oil and gas sectors.
Through its 49%-owned Genting Malaysia Bhd (GenM) and 53%-owned Genting Singapore plc (GenS), which operates Resorts World Genting (RWG) and Resorts World Sentosa (RWS) respectively, Genting is expected to see strong earnings recovery this year on higher contributions from the two subsidiaries.
According to Maybank Investment Bank Research’s (Maybank IB) estimates, GenM and GenS could contribute about RM1.2bil and RM1.1bil, respectively, to Genting’s earnings this year.
Maybank IB says Genting’s target price could be raised to RM8.86 if TauRX gains FDA approval for Alzheimer’s drug
KUALA LUMPUR (Feb 1): Maybank Investment Bank Bhd (Maybank IB) said its target price (TP) for Genting Bhd could be raised to RM8.86 should Genting's 20%-owned TauRX Pharmaceuticals Ltd gain approval from the US Food and Drug Administration (FDA).
In a note, Maybank IB said it will be a watershed year for TauRX as it will submit its lead Alzheimer’s combating investigative drug, Hydromethylthionine Mesylate (HMTM), for the FDA’s approval in the first quarter of 2023.
Marina Bay Sands sees record gaming, retail revenue in Q4 as tourism rebounds SINGAPORE - Amid robust tourism and travel spending recovery across all of Las Vegas Sands’ (LVS) markets, its Singapore integrated resort Marina Bay Sands (MBS) reported a record performance in both mass gaming and retail revenue for the fourth quarter of 2022.
MBS’ net revenue nearly doubled in the fourth quarter of 2022 to US$682 million (S$895 million) from US$368 million in the same period in the year before.
It also reported on Thursday that adjusted property earnings before interest, taxes, depreciation and amortisation (Ebitda) rose 52 per cent to US$273 million from US$177 million a year ago. This was largely driven by a surge in contributions from the casino segment, where rolling chip volume grew year on year to US$7.1 billion in the fourth quarter from just US$1.3 billion the year before.
Hotel occupancy at MBS also grew to 98.3 per cent in the fourth quarter, from 79.1 per cent the previous year, while the average daily rate had more than doubled to hit US$550, from US$259 a year ago.
Revenue per available room also showed significant gains, increasing to US$541 from US$205 in the fourth quarter.
The reopening of business activities and international borders augurs well for Genting Bhd. Its business outlook is likely to turn positive with the reopening of China’s travel borders. The recent uptick in earnings suggests demand is building up after the slowdown in 2020 and 2021.
Genting posted first quarterly net earnings of RM128.02 million in the third quarter ended Sept 30, 2022 (3QFY2022), after six quarters of losses. Quarterly revenue jumped 74.79% year on year to RM6.12 billion from RM3.5 billion.
Compared with Genting Malaysia Bhd, Genting’s business is well diversified with better international exposure. Besides leisure and hospitality, the group is involved in oil palm plantation, power generation, oil and gas, property development, life sciences and biotechnology activities. It also has tie-ups with established names such as Universal Studios, Premium Outlets, Zouk, Hard Rock Hotel, Hilton and other brand partners.
Of the 13 analysts covering the stock, 10 have “buy” calls while three have “hold”. The upside is seen as attractive at 26% against the consensus target price of RM5.90 as tracked by Bloomberg.
SINGAPORE – International visitor arrivals to Singapore are expected to hit 12 million to 14 million in 2023, with full tourism recovery expected by 2024. Tourism receipts are also anticipated to climb to $18 billion to $21 billion.
CIMB, Genting, Hong Leong Bank among foreign investors' top net buy stocks — CGS-CIMB.
KUALA LUMPUR (Jan 10): CIMB Group Holdings Bhd, Genting Bhd and Hong Leong Bank Bhd are among the top net buy stocks of foreign investors, according to CGS-CIMB Research.
Foreign investors turned into the largest net buyers last week (Jan 2 to 6) after net selling in the week before. Their net buy value for Malaysian equities last week was RM72.3 million, the research outfit said in a report.
Net buy value for CIMB was RM55.9 million, followed by Genting (RM26.5 million) and Hong Leong Bank (RM25.2 million).
Genm and Genting Bhd are listed in Bursa Malaysia with market capitalization of about RM16.4 billion (at current share price of RM2.64) and RM18.2 billion (at RM4.71) respectively. These 2 stocks are trading far below their previous peaks of RM5.50-6.00 and RM8.00-9.00 levels in 2017, though the Covid-19 pandemic is largely over in Malaysia and Singapore.
With Malaysia and Singapore welcoming China tourists with open arm from 8th Jan 2023, casinos and the tourism sector in Malaysia and Singapore will do very well in 2023. I expect the share price of Genm and Genting will play catch-up with regional peers, and rebound some 50% to RM4.00 and RM7.00 level in next few weeks.
If Genm and Genting were to catch up on EV/EBITDA valuation with their Macau peers (at minimum 24.1x), Genm and Genting would re-rate by almost 4x to RM10.25 and RM18.00 respectively, purely based on the rebound in business of their existing casino operations in Malaysia and Singapore.
Genting Group Chairman and CEO Lim Kok Thay said, after the launch of RWLV in July 2021, the company would look at listing in the US sooner rather than later amid rising confidence in the US market and the launch of US$4.3 billion RWLV.
Malaysia on strong footing to attract quality investments - Tengku Zafrul In an interview with CNBC this morning, he said that although challenges still remain due to global economic uncertainties, China’s move to reopen its borders next week bodes well for Malaysia, as China is the nation’s largest trading partner.
“Nonetheless, we believe that gaming stocks will continue to chalk higher earnings in 1H2023 (first half of 2023), driven by improvement in business volume. Genting remains our top pick. It should see stronger contribution from its subsidiary Genting Singapore, due to a gradual relaxation of Covid-19 measures in China that should lead to higher visitation of Chinese tourists,” the research outfit added.
The prospect of cash-rich Chinese flocking to shopping streets across the world boosted luxury stocks this week, as China accounts for 21% of the world's 350 billion euro ($371.91 billion) luxury goods market.
Sofitel Sentosa in Singapore is creating Lunar New Year packages aimed at Chinese visitors, including a hotpot buffet and romantic packages for couples, said Cavaliere Giovanni Viterale, general manager of that hotel and the upcoming Raffles Sentosa, as the company bets that a travel rebound will come "with a vengeance".
Good for Genting Sentosa Singapore.
Genting Sentosa Singapore is not under GenM. Genting Sentosa Singapore and TauRX under Genting Berhad.